It's at the London Dorchester (naturally) on September 18/19.
Mr Alain Aragues, President, Cephalon Europe
Dr Kazem Behbehani, Envoy, World Health Organisation
Dr Joseph M Feczko , Chief Medical Officer, Pfizer Inc
Dr Andrew Galazka , SVP, Head of New Therapies, Serono SA
Dr Jean-Jacques Garaud, SVP, Global Head of Exploratory Development, Novartis Pharma AG Professor Sir Charles George, Chair, Board of Science, BMA
Dr Brian Hargreaves, Sector Partner, Healthcare, 3i
Mr Hans Peter Hasler, SVP, Head of International, Biogen Idec
Mr Rolf Hoffmann, SVP, Head of European Operations, Amgen
Dr Melanie Lee, EVP, Head R&D, UCB
Dr John Patterson, Executive Director, Development, AstraZeneca Pharmaceuticals
Dr Claus Steinborn, SVP Global R&D, Solvay Pharmaceuticals GmbH
Dr William Tarr, Medical Director, Quest Diagnostics
Dr Brian Tempest, Chief Mentor & Executive Vice Chairman of the Board, Ranbaxy
Dr Jean-Luc Vanderheyden, Global Molecular Imaging Leader, Technology and Medical Office, GE Healthcare
Dr Mark Walport, Director, Wellcome Trust
Dr Frank Walsh, EVP, Discovery, Wyeth Research
Mr Andrew Witty, President, Pharmaceuticals Europe, GlaxoSmithKline
Don't know someone? This might help.
So Big Pharma's problems should all soon be solved! LOL
The conference should have been called "New hope , more like no hope"
Link
No comments:
Post a Comment